Brian Shaffer, MD, on Promising Signs of Efficacy in Post-CAR-T NHL NK Cell Therapy
The assistant attending physician and bone marrow transplant specialist at Memorial Sloan Kettering Cancer Center discussed updated data on GDA-201 plus rituximab.